Thanks for joining us!
Be sure to view the photo gallery at the end of the page!
We had a blast celebrating the best in digital health with you all at Jazz Night. Special thanks to Chef Solomon Johnson for his amazing and creative food, to Monore for the wonderful venue and drinks, and to Raffi Garabedian and his band for the smooth jazz.
This year we featured some of the most exciting companies in digital health who are working passionately to change healthcare. We were also lucky to have Dr. David Fajgenbaum, writer of Chasing My Cure, share a few words.
Meet Our Speakers
Michelle Longmire, MD is the CEO and founder of Medable and a Stanford-trained physician and entrepreneur driven to improve human health through advances in technology. Prior to founding Medable in 2014, Michelle was a Howard Hughes Research Fellow. She is a board-certified dermatologist who continues to practice today.
Medable is focused on building a unified platform for clinical trial execution, enabling patient generated data to drive clinical research, and precision and predictive medicine. Their mission is to reduce clinical trial times by 50%. Medable has been able to achieve 80% less enrollment time at trial site and $30M in sponsor savings with the aid of direct-to-patient model. Medable is used globally and in almost any language and any country.
Kristi Ebong is Senior Vice President of Strategy and General Manager of Providers at Orbita. Ebong was the former head of emerging technology at Cedars-Sinai, she evaluated and led innovation pilots at Stanford Healthcare and drove thought leadership for Healthspottr’s network of healthcare deal-makers. She also previously served under the Obama Administration in the Office of the National Coordinator for Health IT, and has worked with large healthcare providers, startups, and foundations.
Orbita a conversational AI platform providing voice- and chatbot-powered virtual assistants for healthcare organizations. A leader in voice and chat technologies for consumer and patient engagement, Orbita provides market-proven virtual health assistant solutions built on the most powerful conversational AI platform available to healthcare and life sciences organizations.
Rachel Katz is the founder and CEO at Able Health. She believes value-based care is the project of our generation. She previously worked at Mckinsey and WEF, and is a Fulbright scholar. She has led public-private dialogues at the World Economic Forum, and studied China’s freight industry by hitchhiking 6,000 miles with truckers. She holds a BA from Brown University.
Able Health helps physicians in their journey from volume to value, enabling them to get paid more for delivering better care. Whether MIPS, Medicaid, or commercial initiatives, the platform helps provider organizations track, report, and improve quality. Able’s relentless customer focus has earned them a Net Promoter Score (NPS) +93!
Chris Fernandez – is the CEO and founder of EnsoData and brings more than five years of artificial intelligence and big data research experience to EnsoData. He has a M.S. and B.S. in Biomedical Engineering from UW-Madison. Since EnsoData’s founding, Chris has co-authored 10 peer-reviewed research publications on Artificial Intelligence in Sleep Medicine and frequently serves as a speaker on the evolving role of AI in medicine at international health care and technology conferences.
EnsoData is the industry leading Waveform AI platform in Healthcare. Their EnsoSleep product completes the analysis of sleep studies 75% faster than manual scoring. With the help of AI, clinicians are spending more time with patients and eliminating backlogs. EnsoSleep has scored over 375,000 studies to date, and is trusted by over 270 US sleep centers.
Sirj Goswami is the CEO/Co-founder of InsightRX. He is a trained scientist, specializing in genetics, quantitative pharmacology and data science. His scientific career began at Genentech where he spent two years in research and development and then went on to pursue a PhD at UCSF.
InsightRX leverages patient demographics, biomarkers, genetics, and drug levels to help clinicians prescribe optimal doses of powerful medications, increasing the likelihood of the most therapeutic benefit with the least side effects. InsightRX’s software is currently used across more than 100 drug and therapeutic areas, including oncology and infectious diseases. The company has commercial partnerships with global leaders in the precision medicine space, including UCSF, Stanford and Genentech.
Thanks again to everyone for a great event! We will see you next year.
If there is anything we can do to help, from go-to-market strategy, including sales and marketing advisory/execution, to talent acquisition, please fill out the contact form, and we will reach out to you.
Schedule a free consult .
Visit Wild Horse Productions to download any of the above images.